Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

David Scadden Insider Profile

4 Followers

David Scadden, Director at Agios Pharma, holds 20.42K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Carisma Therapeutics (Ticker: CARM), holds ― shares in Editas Medicine (Ticker: EDIT).

David Scadden's Trading History

AGIOAgios Pharma		Jun 23, 2026DirectorUninformative Buy96.19K$623.80K
DNTHDianthus Therapeutics		Jun 27, 2018DirectorUninformative Buy―$66.62M
EDITEditas Medicine		―Director――
CARMCarisma Therapeutics		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Scadden insider profile FAQ

What is the percentage of profitable transactions made by David Scadden?
The percentage of profitable transactions made by David Scadden is 50%.
What is the average return per transaction made by David Scadden?
The average return per transaction made by David Scadden is -8.60%.
What stocks does David Scadden hold?
David Scadden holds: AGIO, CARM, EDIT, DNTH stocks.
What was David Scadden’s latest transaction?
David Scadden’s latest transaction was an Uninformative Buy of $96.19K.
What was David Scadden's most profitable transaction?
David Scadden’s most profitable transaction was an Informative Buy of DNTH stock on June 27, 2018. The return on the trade was 4.90%.
What is David Scadden's role in Agios Pharma?
David Scadden's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.